Crescent Biopharma (CBIO) News Today $13.19 +1.44 (+12.26%) As of 03:14 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesSEC FilingsSustainabilityTrendsBuy This Stock CBIO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period What is Wedbush's Forecast for CBIO Q2 Earnings?July 16 at 6:25 AM | marketbeat.comWedbush Initiates Coverage of Crescent Biopharma (CBIO) with Outperform RecommendationJuly 15 at 5:56 AM | msn.comWedbush Initiates Coverage on Crescent Biopharma (NASDAQ:CBIO)July 14 at 9:34 AM | marketbeat.comCrescent Biopharma (NASDAQ:CBIO) Upgraded by Wall Street Zen to Sell RatingJuly 12, 2025 | marketbeat.comCrescent Biopharma (NASDAQ:CBIO) Stock Crosses Above Two Hundred Day Moving Average - What's Next?July 11, 2025 | marketbeat.comCrescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific OfficerJuly 8, 2025 | globenewswire.comCrescent Biopharma (NASDAQ:CBIO) Shares Cross Above 200 Day Moving Average - Should You Sell?July 3, 2025 | marketbeat.comCrescent Biopharma, Inc. Common Stock (CBIO) Analyst ResearchJuly 2, 2025 | nasdaq.comCrescent Biopharma Inc. CBIO Company Vitals - U.S. NewsJune 26, 2025 | money.usnews.comStifel Initiates Coverage of Crescent Biopharma (CBIO) with Buy RecommendationJune 26, 2025 | msn.comCatalyst Biosciences, Inc. (CBIO)June 17, 2025 | finance.yahoo.comCrescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 MillionJune 16, 2025 | globenewswire.comCatalyst Biosciences Inc trading halted, volatility trading pauseMarch 19, 2025 | markets.businessinsider.comBiocom California Names the Ninth Annual Life Science Catalyst Award WinnersOctober 29, 2024 | businesswire.comCatalyst Mutual FundsOctober 4, 2024 | morningstar.comMCaribou Biosciences: CB-010, chRDNA Technology Continue To Show Promise In Gene EditingSeptember 30, 2024 | seekingalpha.comStrong Buy Recommendation for Cellectar Biosciences on Positive Phase 2b Results and Solid FinancialsAugust 17, 2024 | markets.businessinsider.comCastle Biosciences, Inc. (CSTL) Q2 2024 Earnings Call TranscriptAugust 6, 2024 | seekingalpha.comNeurocrine Biosciences Heads Into A Catalyst-Rich 2024 With Additional UpsideFebruary 10, 2024 | seekingalpha.comBuy Rating Backed by Pivotal Trial Catalyst and Novel Drug Delivery Platform for Cellectar BiosciencesJanuary 5, 2024 | markets.businessinsider.comBiocom California Names the Eighth Annual Life Science Catalyst Award WinnersNovember 1, 2023 | businesswire.comCatalyst Biosciences Announces Completion of Business Combination With Beijing Continent Pharmaceuticals and Implementation of Name Change and Reverse Stock SplitOctober 30, 2023 | finance.yahoo.comGeneral Catalyst in German VC tie-up as part of European tech pushOctober 23, 2023 | ft.com'Blind Side' author Michael Lewis suggests catalyst behind Michael Oher lawsuit: 'Violence and aggression'October 18, 2023 | foxnews.comIs Catalyst Biosciences (CBIO) Significantly Overvalued?August 23, 2023 | finance.yahoo.comCatalyst Biosciences (CBIO) Earnings Dates & ReportsAugust 22, 2023 | investing.comCBIO - Catalyst Biosciences, Inc.June 9, 2023 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHBI, CBIO, TA, ASRTApril 28, 2023 | markets.businessinsider.comCatalyst Biosciences, Inc. (NASDAQ:CBIO) insiders placed bullish bets worth US$941k in the last 12 monthsApril 3, 2023 | finance.yahoo.com5 Cheap Healthcare Stocks to Buy in 2023March 31, 2023 | insidermonkey.comRaymond James Sticks to Its Hold Rating for Catalyst Biosciences (CBIO)March 31, 2023 | markets.businessinsider.com12 Cheap Healthcare Stocks to Buy in 2023March 29, 2023 | finance.yahoo.comCATALYST BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Catalyst Biosciences, Inc. - CBIOMarch 9, 2023 | prnewswire.comCatalyst Biosciences Shares Are Rallying: What's Driving The Action?February 28, 2023 | msn.comCatalyst Biosciences Provides Corporate UpdateFebruary 28, 2023 | finance.yahoo.comGC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in HematologyFebruary 27, 2023 | finance.yahoo.comCatalyst/Millburn Hedge Strategy IFebruary 5, 2023 | morningstar.comM5 Stocks with the Lowest PE RatioJanuary 19, 2023 | insidermonkey.comSTOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Catalyst Biosciences, Inc. - CBIOJanuary 4, 2023 | prnewswire.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Catalyst Biosciences, Inc. MergerDecember 29, 2022 | wsj.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, BLI, ISO, CBIODecember 29, 2022 | benzinga.comCBIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Catalyst Biosciences, Inc. Is Fair to ShareholdersDecember 28, 2022 | benzinga.comCatalyst Biosciences Third Quarter 2022 Earnings: US$0.15 loss per share (vs US$0.80 loss in 3Q 2021)November 16, 2022 | finance.yahoo.comHow Much Could This Catalyst Boost Shiba Inu in October?October 7, 2022 | fool.comCBIO Catalyst Biosciences, Inc.September 24, 2022 | seekingalpha.comCatalyst Biosciences, Inc. Announces September 21, 2022 as the Ex-Dividend Date for Special Cash Dividend of $1.43 per shareSeptember 1, 2022 | finance.yahoo.comCatalyst Biosciences, Inc. Declares Special Cash Dividend of $1.43 per shareAugust 25, 2022 | finance.yahoo.comBullish insiders at Catalyst Biosciences, Inc. (NASDAQ:CBIO) loaded up on US$1.2m of stock earlier this yearAugust 23, 2022 | nasdaq.comCatalyst Biosciences (NASDAQ:CBIO) investors are sitting on a loss of 71% if they invested three years agoAugust 23, 2022 | finance.yahoo.comCatalyst Biosciences, JDS1 Reach Agreement For Dismissal Of LitigationAugust 19, 2022 | nasdaq.com Get Crescent Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address CBIO Media Mentions By Week CBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CBIO News Sentiment▼0.600.97▲Average Medical News Sentiment CBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CBIO Articles This Week▼80▲CBIO Articles Average Week Get Crescent Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Geron News Today Regulus Therapeutics News Today Zenas BioPharma News Today Myriad Genetics News Today Lexicon Pharmaceuticals News Today Emergent Biosolutions News Today Rigel Pharmaceuticals News Today XOMA Royalty News Today Vanda Pharmaceuticals News Today Verastem News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CBIO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescent Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescent Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CBIO Stock Alerts